ArticleThe Journal of clinical investigation2023

Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases.

Jawad Fares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.